NEWS RELEASES
YEAR
-
CANBRIDGE COMPLETES CHINESE GLIOBLASTOMA BIOMARKER STUDY FOR LEAD CANDIDATE, CAN008 PLANS TO INITIATE PHASE I/II TRIAL IN TAIWAN IN 2016
JAN 11, 2016
-
JAMES XUE,FOUNDER AND CEO OF CANBRIDGE,TO PRESENT AT 2016 EAST WEST CEO CONFERENCE
DEC 17, 2015
-
CANBRIDGE APPOINTS MARK A. GOLDBERG AS ACTING CHIEF MEDICAL OFFICER RAISES ADDITONAL CAPITAL IN SERIES A PLUS ROUND
OCT 22, 2015
-
CANBRIDGE ACQUIRES LICENSE FOR APOGENIX’S APG101 ONCO-IMMUNOTHERAPY IN GLIOBLASTOMA FOR CHINA
JUL 16, 2015
-
CANBRIDGE LIFE SCIENCES, INC. JOINS THE MEDTECH GROUP
APR 08, 2015
-
CANBRIDGE LIFE SCIENCES CEO, JAMES XUE, PRESENTING AT CANCER ADVANCED BOSTON AND BOSTON CEO
APR 02, 2015
-
JAMES XUE, FOUNDER AND CEO OF CANBRIDGE, TO PRESENT AT 2015 EAST WEST CEO CONFERENCE
DEC 15, 2014
-
CANBRIDGE LIFE SCIENCES RAISES $10 MILLION IN SERIES A ROUND LED BY QIMING VENTURE PARTNERS
DEC 03, 2014
